Cellectar Biosciences Ownership 2024 | Who Owns Cellectar Biosciences Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

2.84%

Institutional Holders

1.00

Cellectar Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

Cellectar Biosciences's largest institutional shareholder is MENDOTA FINANCIAL GROUP, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

The largest Cellectar Biosciences shareholder by % of total assets is MENDOTA FINANCIAL GROUP, LLC. The company owns 0.00 shares of Cellectar Biosciences (CLRB), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Cellectar Biosciences's largest institutional buyer is MENDOTA FINANCIAL GROUP, LLC. The company purchased -5.00 stocks of CLRB, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Cellectar Biosciences's biggest institutional seller is MENDOTA FINANCIAL GROUP, LLC. The company sold -5.00 shares of CLRB, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

Cellectar Biosciences's largest sold out institutional shareholder by shares sold is MENDOTA FINANCIAL GROUP, LLC, sold -5.00 shares, valued at -, as of undefined.

Cellectar Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.01%	3,510	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	1,650,818	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	422,731	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	46,083	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	22,909	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	7,984	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	32,146	-	-	Jan 31, 2024
Legg Mason Global Asset Management Trust	0.00%	101,244	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	2,400	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	2,031	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,012	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	10,900	10,963	-17401.59%	Mar 31, 2021
EQ ADVISORS TRUST	0.00%	3,208	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	43,190	-	-	Mar 31, 2024
Legg Mason Global Asset Management Trust	0.00%	10,124	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,568	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	377	-	-	Mar 31, 2024

Cellectar Biosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 3.51K shares, compromising 0.01% of its total assets.

Cellectar Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	1	-
31 Mar, 23	1	-
30 Sep, 22	1	-96.43%
30 Jun, 22	28	-
31 Mar, 22	28	-20.00%
31 Dec, 21	35	-
30 Sep, 21	35	-14.63%
30 Jun, 21	41	-2.38%
31 Mar, 21	42	13.51%
31 Dec, 20	37	94.74%
30 Sep, 20	19	-9.52%
30 Jun, 20	21	40.00%
31 Mar, 20	15	50.00%
31 Dec, 19	10	-16.67%
30 Sep, 19	12	20.00%
30 Jun, 19	10	11.11%
31 Mar, 19	9	-
31 Dec, 18	9	-18.18%
30 Sep, 18	11	1000.00%
30 Jun, 18	1	-

As of 30 Jun 23, 1 institutions are holding Cellectar Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	5	-
31 Mar, 23	5	-
30 Sep, 22	5	-100.00%
30 Jun, 22	6,561,180	-3.30%
31 Mar, 22	6,784,960	3.48%
31 Dec, 21	6,557,045	-10.02%
30 Sep, 21	7,287,078	-41.51%
30 Jun, 21	12,459,505	-17.09%
31 Mar, 21	15,027,195	-14.93%
31 Dec, 20	17,664,507	411.64%
30 Sep, 20	3,452,550	20.44%
30 Jun, 20	2,866,552	95.50%
31 Mar, 20	1,466,269	13.01%
31 Dec, 19	1,297,481	-13.86%
30 Sep, 19	1,506,169	-19.87%
30 Jun, 19	1,879,728	661.29%
31 Mar, 19	246,914	-6.02%
31 Dec, 18	262,722	-51.50%
30 Sep, 18	541,706	648.39%
30 Jun, 18	72,383	-

Cellectar Biosciences (CLRB) has 5.00 shares outstanding as of 30 Jun 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-
30 Sep, 22	0.00%	-
30 Jun, 22	107.38%	0.87%
31 Mar, 22	111.04%	0.80%
31 Dec, 21	118.11%	0.80%
30 Sep, 21	121.72%	0.22%
30 Jun, 21	236.14%	0.24%
31 Mar, 21	312.16%	0.23%
31 Dec, 20	366.95%	2.13%
30 Sep, 20	131.14%	0.30%
30 Jun, 20	207.82%	0.85%
31 Mar, 20	156.16%	0.55%
31 Dec, 19	169.05%	0.66%
30 Sep, 19	160.46%	0.22%
30 Jun, 19	269.95%	10.09%
31 Mar, 19	51.73%	0.66%
31 Dec, 18	88.70%	0.31%
30 Sep, 18	170.09%	9.73%
30 Jun, 18	41.80%	-

As of 30 Jun 23, Cellectar Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-
30 Sep, 22	-	-100.00%
30 Jun, 22	9	28.57%
31 Mar, 22	7	-50.00%
31 Dec, 21	14	-17.65%
30 Sep, 21	17	-34.62%
30 Jun, 21	26	-3.70%
31 Mar, 21	27	-10.00%
31 Dec, 20	30	233.33%
30 Sep, 20	9	-30.77%
30 Jun, 20	13	85.71%
31 Mar, 20	7	75.00%
31 Dec, 19	4	-20.00%
30 Sep, 19	5	25.00%
30 Jun, 19	4	100.00%
31 Mar, 19	2	-50.00%
31 Dec, 18	4	-63.64%
30 Sep, 18	11	1000.00%
30 Jun, 18	1	-

- institutional shareholders have increased their position in CLRB stock as of 30 Jun 23 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-
30 Sep, 22	-	-100.00%
30 Jun, 22	6	50.00%
31 Mar, 22	4	-33.33%
31 Dec, 21	6	20.00%
30 Sep, 21	5	-
30 Jun, 21	5	-16.67%
31 Mar, 21	6	200.00%
31 Dec, 20	2	-60.00%
30 Sep, 20	5	150.00%
30 Jun, 20	2	-33.33%
31 Mar, 20	3	-
31 Dec, 19	3	50.00%
30 Sep, 19	2	100.00%
30 Jun, 19	1	-50.00%
31 Mar, 19	2	100.00%
31 Dec, 18	1	-
30 Sep, 18	-	-
30 Jun, 18	-	-

- institutional shareholders have reduced their position in CLRB stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	1	-	5	-	-	-	-	-100.00%	-	-
31 Mar, 23	1	-	5	-	-	-	1	-	-	-
30 Sep, 22	1	-96.43%	5	-100.00%	0.00%	-	-	-100.00%	-	-100.00%
30 Jun, 22	28	-	6,561,180	-3.30%	107.38%	0.87%	9	28.57%	6	50.00%
31 Mar, 22	28	-20.00%	6,784,960	3.48%	111.04%	0.80%	7	-50.00%	4	-33.33%
31 Dec, 21	35	-	6,557,045	-10.02%	118.11%	0.80%	14	-17.65%	6	20.00%
30 Sep, 21	35	-14.63%	7,287,078	-41.51%	121.72%	0.22%	17	-34.62%	5	-
30 Jun, 21	41	-2.38%	12,459,505	-17.09%	236.14%	0.24%	26	-3.70%	5	-16.67%
31 Mar, 21	42	13.51%	15,027,195	-14.93%	312.16%	0.23%	27	-10.00%	6	200.00%
31 Dec, 20	37	94.74%	17,664,507	411.64%	366.95%	2.13%	30	233.33%	2	-60.00%
30 Sep, 20	19	-9.52%	3,452,550	20.44%	131.14%	0.30%	9	-30.77%	5	150.00%
30 Jun, 20	21	40.00%	2,866,552	95.50%	207.82%	0.85%	13	85.71%	2	-33.33%
31 Mar, 20	15	50.00%	1,466,269	13.01%	156.16%	0.55%	7	75.00%	3	-
31 Dec, 19	10	-16.67%	1,297,481	-13.86%	169.05%	0.66%	4	-20.00%	3	50.00%
30 Sep, 19	12	20.00%	1,506,169	-19.87%	160.46%	0.22%	5	25.00%	2	100.00%
30 Jun, 19	10	11.11%	1,879,728	661.29%	269.95%	10.09%	4	100.00%	1	-50.00%
31 Mar, 19	9	-	246,914	-6.02%	51.73%	0.66%	2	-50.00%	2	100.00%
31 Dec, 18	9	-18.18%	262,722	-51.50%	88.70%	0.31%	4	-63.64%	1	-
30 Sep, 18	11	1000.00%	541,706	648.39%	170.09%	9.73%	11	1000.00%	-	-
30 Jun, 18	1	-	72,383	-	41.80%	-	1	-	-	-

Cellectar Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 18, 2024	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	500,000	$2.65	$1.32M	500,000
Jun 18, 2024	CARUSO JAMES V	director, officer	President and CEO	A-Award	Buy	900,000	$2.65	$2.38M	900,000
Jun 18, 2024	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	290,000	$2.65	$768.50K	290,000
Jun 18, 2024	Shustov Andrei	officer	Senior Vice President, Medical	A-Award	Buy	260,000	$2.65	$689.00K	260,000
Jun 18, 2024	Lea Darrell Shane	officer	Chief Commercial Officer	A-Award	Buy	260,000	$2.65	$689.00K	260,000
Jun 18, 2024	Loren Stefan	director	-	A-Award	Buy	60,000	$2.58	$154.80K	60,000
Jun 18, 2024	Swirsky Douglas J	director	-	A-Award	Buy	90,000	$2.58	$232.20K	90,000
Jun 18, 2024	NEIS JOHN	director	-	A-Award	Buy	60,000	$2.58	$154.80K	60,000
Jun 18, 2024	DRISCOLL FREDERICK W	director	-	A-Award	Buy	60,000	$2.58	$154.80K	60,000
Jun 18, 2024	Chanan-Khan Asher	director	-	A-Award	Buy	60,000	$2.58	$154.80K	60,000
Dec 12, 2023	Lea Darrell Shane	officer	Chief Commercial Officer	A-Award	Buy	100,000	$1.68	$168.00K	100,000
Dec 12, 2023	Lea Darrell Shane	officer	Chief Commercial Officer	A-Award	Buy	39,599	-	-	39,599
Dec 12, 2023	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	104,000	$1.68	$174.72K	104,000
Dec 12, 2023	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	42,554	-	-	42,578
Dec 12, 2023	Shustov Andrei	officer	Senior Vice President, Medical	A-Award	Buy	47,856	-	-	55,037
Dec 12, 2023	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	144,000	$1.68	$241.92K	144,000
Dec 12, 2023	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	42,927	-	-	53,141
Dec 12, 2023	CARUSO JAMES V	director, officer	President and CEO	A-Award	Buy	261,000	$1.68	$438.48K	261,000
Dec 12, 2023	CARUSO JAMES V	director, officer	President and CEO	A-Award	Buy	40,596	-	-	49,236
Jun 28, 2023	Swirsky Douglas J	director	-	A-Award	Buy	37,500	$1.85	$69.38K	71,925

Cellectar Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	5	-	-
Q1 2023	4	1	400.00%
Q4 2022	1	-	-
Q2 2022	5	-	-
Q1 2022	4	1	400.00%
Q3 2021	2	-	-
Q2 2021	5	-	-
Q1 2021	6	5	120.00%
Q4 2020	3	-	-
Q3 2020	1	1	100.00%
Q2 2020	12	-	-
Q1 2020	7	-	-
Q3 2019	1	-	-
Q2 2019	5	-	-
Q1 2019	4	-	-
Q4 2018	12	2	600.00%
Q3 2018	1	-	-
Q2 2018	1	-	-
Q1 2018	-	2	-
Q4 2017	-	1	-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cellectar Biosciences's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	2	-	-
Q2 2021	-	-	-
Q1 2021	1	6	16.67%
Q4 2020	3	-	-
Q3 2020	-	-	-
Q2 2020	7	-	-
Q1 2020	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	1	-	-
Q4 2018	1	4	25.00%
Q3 2018	1	-	-
Q2 2018	-	-	-
Q1 2018	-	2	-
Q4 2017	-	1	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cellectar Biosciences's stocks.

Cellectar Biosciences Peer Ownership

Ticker	Company
MNPR	Monopar Therapeutics Inc.
NXTC	NextCure, Inc.
PULM	Pulmatrix, Inc.
BPTH	Bio-Path Holdings, Inc.
CAPR	Capricor Therapeutics, Inc.
DFFN	CervoMed Inc.
TENX	Tenax Therapeutics, Inc.
BOLT	Bolt Biotherapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.
BNTC	Benitec Biopharma Inc.
ALRN	Aileron Therapeutics, Inc.
LBPH	Longboard Pharmaceuticals, Inc.
LUMO	Lumos Pharma, Inc.

CLRB Ownership FAQ

Who Owns Cellectar Biosciences?

Cellectar Biosciences is owned by institutional shareholders (0%), insiders (2.84%), and public (0%). The largest institutional shareholder of Cellectar Biosciences is MENDOTA FINANCIAL GROUP, LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).

Who are the major institutional shareholders of Cellectar Biosciences?

Cellectar Biosciences's major institutional shareholders are MENDOTA FINANCIAL GROUP, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Cellectar Biosciences shareholders are there?

As of Jun 2023, there are 1 institutional shareholders of Cellectar Biosciences.

What percentage of Cellectar Biosciences is owned by MENDOTA FINANCIAL GROUP, LLC?

MENDOTA FINANCIAL GROUP, LLC owns 0 shares of Cellectar Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).